Literature DB >> 1347994

C-type natriuretic peptide is a potent activator of guanylate cyclase in endothelial cells from brain microvessels.

P Vigne1, C Frelin.   

Abstract

An exposure of endothelial cells from rat brain microvessels to C-type natriuretic peptide (CNP) resulted in a rapid and large increase in cGMP formation. The action of CNP did not require inhibitors of phosphodiesterases to be observed and occurred at nanomolar concentrations. Other natriuretic peptides (ANP and BNP) also stimulated cGMP formation in endothelial cells from brain microvessels but with a potency that was at least 100 times less than that of CNP. In contrast, endothelial cells from the aorta showed large cGMP responses to low concentrations of ANP and BNP but were unresponsive to CNP up to concentrations as large as 100 nM. It is concluded that endothelial cells from brain microvessels and from aorta express different receptors subtypes for natriuretic peptides. Endothelial cells from brain microvessels express CNP specific ANPB receptors; aortic endothelial cells express ANP (and BNP) specific ANPA receptors. CNP may play an important role in the regulation of water and electrolyte movements across the blood brain barrier.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347994     DOI: 10.1016/0006-291x(92)90530-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Neuroendocrine changes in chronic cardiac failure.

Authors:  D P Nicholls; G N Onuoha; G McDowell; J S Elborn; M S Riley; A M Nugent; I C Steele; C Shaw; K D Buchanan
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

2.  C-type natriuretic peptide modulates permeability of the blood-brain barrier.

Authors:  Manoj Bohara; Yuki Kambe; Tetsuya Nagayama; Hiroshi Tokimura; Kazunori Arita; Atsuro Miyata
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-08       Impact factor: 6.200

3.  The role of guanylyl cyclases in the permeability response to inflammatory mediators in pial venular capillaries in the rat.

Authors:  M H Sarker; P A Fraser
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

4.  C-Type Natriuretic Peptide Ameliorates Vascular Injury and Improves Neurological Outcomes in Neonatal Hypoxic-Ischemic Brain Injury in Mice.

Authors:  Guofang Shen; Shirley Hu; Zhen Zhao; Lubo Zhang; Qingyi Ma
Journal:  Int J Mol Sci       Date:  2021-08-20       Impact factor: 6.208

5.  Characterization of natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour cell line.

Authors:  A F Gilkes; P H Ogden; S B Guild; G Cramb
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

6.  Natriuretic peptide-induced cyclic GMP accumulation in adult guinea-pig cerebellar slices.

Authors:  F Hernández; S P Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

7.  C-type natriuretic peptide preserves central neurological function by maintaining blood-brain barrier integrity.

Authors:  Cristina Perez-Ternero; Patrick N Pallier; Jordi L Tremoleda; Alessio Delogu; Cathy Fernandes; Adina T Michael-Titus; Adrian J Hobbs
Journal:  Front Mol Neurosci       Date:  2022-10-04       Impact factor: 6.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.